The short version of Cardarine fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-10 and is reviewed periodically as new material appears.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ | Nuclear receptor; not androgen receptor |
| Studied indications | Dyslipidemia; obesity; diabetes | Early clinical research; development discontinued |
| Rodent toxicity | Tumor formation in multiple tissues | Dose-dependent findings in some studies |
| Human approval | None | No approved therapeutic use |
| Typical analytical method | LC-MS/MS | Used for identity and quantification |
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
=== Pyrimidines === Uridine phosphorylase or pyrimidine-nucleoside phosphorylase substitutes the anomeric-carbon-bonded phosphate of ribose 1-phosphate for the free base uracil, forming the nucleoside uridine. Uridine kinase (aka uridine–cytidine kinase) can then phosphorylate the 5’-carbon of this nucleoside into uridine monophosphate (UMP). UMP/CMP kinase (EC 2.7.4.14) can phosphorylate UMP into uridine diphosphate, which nucleoside diphosphate kinase can phosphorylate into uridine triphosphate. Thymidine phosphorylase or pyrimidine-nucleoside phosphorylase adds 2-deoxy-alpha-D-ribose 1-phosphate to thymine, with thymine bonding at the anomeric carbon of the deoxyribose, forming the deoxynucleoside thymidine. Thymidine kinase can then phosphorylate the 5’-carbon of this compound into thymidine monophosphate (TMP). Thymidylate kinase can phosphorylate TMP into thymidine diphosphate, which nucleoside diphosphate kinase can phosphorylate into thymidine triphosphate. The nucleosides cytidine and deoxycytidine can be salvaged along the uracil pathway by cytidine deaminase, which converts them to uridine and deoxyuridine, respectively. Alternatively, uridine–cytidine kinase can phosphorylate them into cytidine monophosphate (CMP) or deoxycytidine monophosphate (dCMP). UMP/CMP kinase can phosphorylate (d)CMP into cytidine diphosphate or deoxycytidine diphosphate, which nucleoside diphosphate kinase can phosphorylate into cytidine triphosphate or deoxycytidine triphosphate.
=== Languages === The official language of Schleswig-Holstein is German. In addition, Low German, Danish and North Frisian are recognized minority languages. Historically, Low German (in Holstein and Southern Schleswig), Danish (in Schleswig), and North Frisian (in Western Schleswig) were widely spoken in Schleswig-Holstein. During the language change in the 19th century some Danish and North Frisian dialects in Southern Schleswig were replaced by Standard German. Low German is still used in many parts of the state. Missingsch, a Low German dialect with heavy High German (Standard German) influence, is commonly spoken informally throughout the state, while a mixed language Petuh (mixture of High German and Danish) is used in and around Flensburg. Danish is used by the Danish minority in Southern Schleswig, and North Frisian is spoken by the North Frisians of the North Sea Coast and the Northern Frisian Islands in Southern Schleswig. The North Frisian dialect called Heligolandic (Halunder) is spoken on the island of Heligoland. As is the case throughout Germany, High German, introduced in the 16th century, has come to steadily replace local dialects for official purposes, and is today the predominant language of media, law, and legislature. It is spoken by virtually all inhabitants in formal situations. Since the end of World War II and the widespread adoption of TV, radio, and other mass media, it has gradually come to supplant local dialects in urban areas as well.
=== Music === The Link (album), by French death metal band Gojira Links (Kerfuffle album), 2006, by English folk band Kerfuffle Links (Mark Murphy album), a 2001 album by Mark Murphy "Link", a 2005 song by L'Arc-en-Ciel "Link", a 2007 song by Porno Graffitti "Links", a 2023 song by Indo-Canadian rapper Sukha
In September 2011, Colombian authorities seized a 16-meter-long submersible that could hold a crew of 5, costing about $2 million. The vessel belonged to FARC rebels and had the capacity to carry at least 7 tonnes of drugs.
The manifestation of apical dominance differs significantly between plant groups due to the positioning of their growing points (meristems): Broadleaf plants: The apical meristem is located at the shoot tip, elevated above the ground. Apical dominance is exerted downward, inhibiting axillary buds along the stem. Removing the apex (pruning) releases these buds, resulting in lateral branching and a bushier shape. Grasses: During vegetative growth, the primary apical meristem remains at or near the soil surface in a region called the crown. Growth occurs via intercalary meristems at the base of the leaves. Apical dominance in grasses primarily regulates tillering—the production of new shoots from basal buds. Because the meristem is protected at ground level, grasses can be mown or grazed without destroying the primary growing point, allowing them to recover more quickly than most broadleaf species. Plant physiologists have identified four different stages the plant goes through after the apex is removed (Stages I-IV). The four stages are referred to as:
Sources: en.wikipedia.org
Np(VII) is dark green in a strongly basic solution. Though its chemical formula in basic solution is frequently cited as NpO3−5, this is a simplification and the real structure is probably closer to a hydroxo species like [NpO4(OH)2]3−. Np(VII) was first prepared in basic solution in 1967. In strongly acidic solution, Np(VII) is found as NpO+3; water quickly reduces this to Np(VI). Its hydrolysis products are uncharacterized.
Researchers are actively working to improve the power density, safety, cycle durability (battery life), recharge time, cost, flexibility, and other characteristics, as well as research methods and uses, of these batteries. Solid-state batteries are being researched as a breakthrough in technological barriers. Currently, solid-state batteries are expected to be the most promising next-generation battery, and various companies are working to popularize them. Research areas for lithium-ion batteries include extending lifetime, increasing energy density, improving safety, reducing cost, and increasing charging speed, among others. Research has been under way in the area of non-flammable electrolytes as a pathway to increased safety based on the flammability and volatility of the organic solvents used in the typical electrolyte. Strategies include aqueous lithium-ion batteries, ceramic solid electrolytes, polymer electrolytes, ionic liquids, and heavily fluorinated systems. One of the ways to improve batteries is to combine the various cathode materials. This allows researchers to improve on the qualities of a material, while limiting the negatives. One possibility is coating lithium nickel manganese oxide with lithium iron phosphate through resonant acoustic mixing. The resulting material benefits from an increase electrochemical performance and improved capacity retention. Similar work was done with iron (III) phosphate.
=== Refactoring === The process of rearranging the sets of backups in an archive file is known as refactoring. For example, if a backup system uses a single tape each day to store the incremental backups for all the protected computers, restoring one of the computers could require many tapes. Refactoring could be used to consolidate all the backups for a single computer onto a single tape, creating a "synthetic full backup". This is especially useful for backup systems that do incrementals forever style backups.
=== Immunomodulatory treatments === In PBC, the liver is filled with T cells and B cells that contribute to a worsening condition. Therefore, some treatments are looking into targeting the antigens of these immune cells. The monoclonal antibody rituximab targets the CD20 antigen on the B cells, and is already used in a wide array of other rheumatologic diseases. In an open-label study, six patients that were unresponsive to UDCA had improvement in ALP levels after rituximab infusions. However, the efficacy of rituximab is still uncertain, and awaits further studies and trials. PBC can also lead to higher levels of interleukin 12 and interleukin 23. This was what motivated researches to look at the viability of ustekinumab, a monoclonal antibody targeted against interleukin 12 and 23. An experiment found though it did not significantly improve serum ALP levels. The researchers were further even criticized for placing patients at risk by allowing them to move to advanced disease stages where immunomodulatory therapies may not even be an option.
Stalin's plans for the city included a network of broad avenues and roadways, some of them more than ten lanes wide, which—while significantly simplifying movement through the city—were constructed at the expense of many historical buildings and districts. Among the many losses from Stalin's demolitions were the Sukharev Tower, an old city landmark, as well as mansions and commercial buildings. The city's new status as the capital of a strongly secular nation made religiously significant buildings particularly vulnerable to demolition. Many of the city's churches—in most cases some of Moscow's oldest and most prominent buildings—were destroyed. Notable examples of this destruction include Kazan Cathedral and the Cathedral of Christ the Saviour. During the 1990s, both cathedrals were rebuilt. Many smaller churches, however, were lost.
Sources: en.wikipedia.org
Despite its apparent importance in hydrogen peroxide removal, humans with genetic deficiency of catalase — "acatalasemia" — or mice genetically engineered to lack catalase completely, experience few ill effects.
=== Cardiac arrest === While intravenous calcium has been used in cardiac arrest, its general use is not recommended. Cases of cardiac arrest in which it is still recommended include high blood potassium, low blood calcium such as may occur following blood transfusions, and calcium channel blocker overdose. There is the potential that general use could worsen outcomes. If calcium is used, calcium chloride is generally the recommended form.
=== Secondary metabolites === Starfish produce a large number of secondary metabolites in the form of lipids, including steroidal derivatives of cholesterol, and fatty acid amides of sphingosine. The steroids are mostly saponins, known as asterosaponins, and their sulphated derivatives. They vary across species and are typically formed from up to six sugar molecules (usually glucose and galactose) connected by up to three glycosidic chains. Long-chain fatty acid amides of sphingosine occur frequently, with some having known biological activity. Starfish also contain various ceramides and a small number of alkaloids. These chemicals in the starfish may function in defence and communication. Some are feeding deterrents used by the starfish to discourage predation. Others are antifoulants and supplement the pedicellariae to prevent other organisms from settling on the starfish's aboral surface. Some are alarm pheromones and escape-eliciting chemicals, the release of which trigger responses in starfish of the same species, but often stimulate flight in potential prey. Research into the efficacy of these compounds for possible pharmacological or industrial use occurs worldwide.
=== Visual effects === Zoic Studios provided visual effects for the series. According to Johns, Stargirl was the first Warner Bros. Television series to use previsualization (a process most commonly used by feature films) for their effects scenes. Previsualization was handled by The Third Floor, Inc. Johns brought his experience working on the films Wonder Woman (2017), Aquaman (2018), and Shazam! (2019) to help the series have visuals not "seen in superhero shows before".
Sources: en.wikipedia.org
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.
Rodent studies found dose-dependent tumors in several organs. The sponsor discontinued the program over cancer concerns. Human risk from long-term use remains unknown.
Controlled human endurance trials are lacking. Animal studies show increased exercise capacity under some conditions. Anecdotal reports are not equivalent to clinical evidence.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.